Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 3801976, 9 pages
https://doi.org/10.1155/2017/3801976
Research Article

Naoxintong/PPAR Signaling Inhibits Cardiac Hypertrophy via Activation of Autophagy

1Institute of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, China
2Department of Oncology, Affiliated Wujin People’s Hospital, Jiangsu University, Changzhou 212017, China
3Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 312 Anshanxi Road, Nankai District, Tianjin 300193, China
4Tianjin Key Laboratory of Traditional Chinese Medicine Pharmacology, Tianjin University of Traditional Chinese Medicine, 88 Yuquan Road, Nankai District, Tianjin 300193, China
5Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae (Tianjin University of Traditional Chinese Medicine), Ministry of Education, Tianjin 300193, China

Correspondence should be addressed to Yongzhong Hou; nc.ude.sju.liam@zyuoh and Hong Wang; moc.621@sysgnohgnaw

Received 16 August 2016; Accepted 1 December 2016; Published 15 February 2017

Academic Editor: Kuzhuvelil B. Harikumar

Copyright © 2017 Shuping Yuan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Su, Y. Li, B. Lv et al., “Clinical study on Naoxintong capsule for stroke recovery of Qi-deficiency and blood-stasis syndrome,” Zhongguo Zhong Yao Za Zhi, vol. 36, no. 11, pp. 1530–1533, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. S.-R. Li, T.-H. Wang, and B.-J. Zhang, “[Effects of naoxintong capsule on the inflammation and prognosis in borderline lesion coronary heart disease patients],” Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban, vol. 32, no. 5, pp. 607–611, 2012. View at Google Scholar · View at Scopus
  3. X.-N. Zhong, H.-H. Wang, Z.-Q. Lu et al., “Effects of naoxintong on atherosclerosis and inducible nitric oxide synthase expression in atherosclerotic rabbit,” Chinese Medical Journal, vol. 126, no. 6, pp. 1166–1170, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Zhao, H. Zhu, S. Wang et al., “Naoxintong protects against atherosclerosis through lipid-lowering and inhibiting maturation of dendritic cells in LDL receptor knockout mice fed a high-fat diet,” Current Pharmaceutical Design, vol. 19, no. 33, pp. 5891–5896, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Xu, M. You, H. Shi, and Y. Hou, “Ubiquitin-mediated NFκB degradation pathway,” Cellular and Molecular Immunology, vol. 12, no. 6, pp. 653–655, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Zhang, B. Huang, Y. Zhao et al., “BNC protects H9c2 cardiomyoblasts from H2O2-induced oxidative injury through ERK1/2 signaling pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 802784, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Grivennikov, E. Karin, J. Terzic et al., “IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer,” Cancer Cell, vol. 15, no. 2, pp. 103–113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Nakai, O. Yamaguchi, T. Takeda et al., “The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress,” Nature Medicine, vol. 13, no. 5, pp. 619–624, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Kaur and J. Debnath, “Autophagy at the crossroads of catabolism and anabolism,” Nature Reviews Molecular Cell Biology, vol. 16, no. 8, pp. 461–472, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Michalik, B. Desvergne, and W. Wahli, “Peroxisome-proliferator-activated receptors and cancers: complex stories,” Nature Reviews Cancer, vol. 4, no. 1, pp. 61–70, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Hou, F. Moreau, and K. Chadee, “PPARγ is an E3 ligase that induces the degradation of NFκB/p65,” Nature Communications, vol. 3, article 1300, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Hou, J. Gao, H. Xu et al., “PPARγ E3 ubiquitin ligase regulates MUC1-C oncoprotein stability,” Oncogene, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. Z. Zhang, Y. Xu, Q. Xu, and Y. Hou, “PPARγ against tumors by different signaling pathways,” Onkologie, vol. 36, no. 10, pp. 598–601, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. J. M. Lee, M. Wagner, R. Xiao et al., “Nutrient-sensing nuclear receptors coordinate autophagy,” Nature, vol. 516, no. 7529, pp. 112–115, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. C. H. Jung, S.-H. Ro, J. Cao, N. M. Otto, and D.-H. Kim, “mTOR regulation of autophagy,” FEBS Letters, vol. 584, no. 7, pp. 1287–1295, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Xu, J. Jin, L. Chen et al., “Naoxintong/PPARα signaling inhibits H9c2 cell apoptosis and autophagy in response to oxidative stress,” Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 4370381, 10 pages, 2016. View at Publisher · View at Google Scholar
  17. X. Ma, B. Lv, P. Li et al., “Identification of ‘multiple components-multiple targets-multiple pathways’ associated with naoxintong capsule in the treatment of heart diseases using UPLC/Q-TOF-MS and network pharmacology,” Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 9468087, 15 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Ma, P. Zhao, J. Zhu et al., “Naoxintong Protects primary neurons from oxygen-glucose deprivation/reoxygenation induced injury through PI3K-Akt signaling pathway,” Evidence-based Complementary and Alternative Medicine, vol. 2016, Article ID 5815946, 12 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. M.-W. Huang, H. Wang, W.-J. Zhong, X.-Y. Wu, and H. Chen, “Chinese herbal medicine Naoxintong capsule combined with dual antiplatelet therapy in a rat model of coronary microembolization induced by homologous microthrombi,” Journal of Chinese Integrative Medicine, vol. 9, no. 1, pp. 38–48, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Mizushima and D. J. Klionsky, “Protein turnover via autophagy: implications for metabolism,” Annual Review of Nutrition, vol. 27, pp. 19–40, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Hariharan, Y. Ikeda, C. Hong et al., “Autophagy plays an essential role in mediating regression of hypertrophy during unloading of the heart,” PLOS ONE, vol. 8, no. 1, Article ID e51632, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Li, C. Chen, F. Yao et al., “AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1,” Archives of Biochemistry and Biophysics, vol. 558, pp. 79–86, 2014. View at Publisher · View at Google Scholar · View at Scopus